Bruns Vi N, Tressler EH, Vendruscolo LF, Leggio L, Farokhnia M
GLP-1s, such as exenatide and liraglutide, enhance the activity of GLP-1 receptors, thereby stimulating insulin secretion, suppressing glucagon release, and slowing down the emptying of the stomach
Its worth noting that all these additional benefits were observed before the actual weight loss, so they seem to be a result of the GLP-1 and not the weight loss
Semaglutide GLP-1, along with personalized guidance, provides a comprehensive approach to weight loss and blood sugar management
Metabolic adaptation maximized
Based on boxplot analysis, all three methods very accurately estimated the expected ratios on median across all comparisons (Fig